-
Alnylam Pharmaceutical Surges After Rare Disease Drug Met Key Endpoints
Wednesday, September 20, 2017 - 8:25am | 415Read More...Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) surged higher by more than 20 percent early Wednesday morning after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through...
-
Alnylam Pharmaceuticals Dips Lower After Company Announces 2016 Pipeline Goals Towards 'Alnylam 2020'
Monday, January 11, 2016 - 2:57pm | 171Read More...Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) were trading lower by nearly 7 percent at $78.74 mid-Monday afternoon after the company announced its pipeline goals for 2016 across its various segments. Alnylam Pharmaceuticals noted that by the end of 2020 it expects to achieve a profile...
